NPI registry status
Active
2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1679543680 M.D.
Verify on CMS → Aron Rose, M.D.
Glaucoma Specialist (Ophthalmology) Physician in Waterbury, Connecticut.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 356 in Glaucoma Specialist (Ophthalmology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 339 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
68%
generic claims · 32% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.4/100
▲ 6 pts above national avg 83.1 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Aron Rose, M.D. reported a CMS MIPS final score of 89.4/100 - above the 83.1 national average - and filed 1,577 Medicare Part D claims in 2023.
- 89.4/100
- MIPS score · +6 vs avg
- 2K
- Part D claims, 2023
- 68%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Aron Rose, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
89 Top 42% higher than 58% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Aron Rose, M.D. sits
This provider among glaucoma specialist (ophthalmology) physician peers
Across the 216 glaucoma specialist (ophthalmology) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Aron Rose, M.D. writes more Part D claims than 25% of them and scores higher on MIPS quality than 55% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one glaucoma specialist (ophthalmology) physician peer from a representative sample of 60; the gold marker is Aron Rose, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Aron Rose, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Aron Rose, M.D.?
High performer (top quartile)Primary specialty
Glaucoma Specialist (Ophthalmology) Physician
Medicare Part D claims
1,577 47% vs specialty avg
MIPS final score
89.4/100 6.3 pts vs avg
Specialty distribution in Connecticut
How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among Connecticut providers
Medicare quality performance, MIPS
Aron Rose, M.D.'s 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average
- MIPS Final Score
- 89.4/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) - 89.4/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Aron Rose, M.D. appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding M.D. credentials at 1201 W MAIN ST, Waterbury, CT, 06708, with a listed phone of (203) 597-9100. NPI 1679543680 was issued on 01/23/2006.
Medicare Part D records for calendar year 2023 show 1,577 prescription claims written by this provider, covering 339 Medicare beneficiaries and totaling roughly $135K in drug spend, split 32% brand-name and 68% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 89.4/100 for the 2023 performance year (Quality 100, Cost 64.7), compared with the national average of 83.1.
Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 356 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1679543680 |
|---|---|
| Specialty | Glaucoma Specialist (Ophthalmology) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 01/23/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
89.3965
Final Score
Avg: 83.1
100
Quality
64.655
Cost
Reporting: Group practice
Brand vs generic prescribing mix · Above average
Aron Rose, M.D. - brand share 32.0%
Glaucoma Specialist (Ophthalmology) Physician average
32% brand-name claims vs 68% generic, on 1,577 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,577
Total Claims
$135K
Total Drug Cost
339
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,832
- Total Day Supply
- 80,334
- Brand vs Generic
- 32% brand / 68% generic
- Brand Drug Cost
- $105K
- Generic Drug Cost
- $30K
Patient Demographics
- Average Patient Age
- 78.5 years
- Avg HCC Risk Score
- 1.09
- Gender Split
- 63% female / 37% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Aron Rose, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
607 claims
- Ofloxacin 170
Ofloxacin
170 claims
- Prednisolone Acetate 169
Prednisolone Acetate
169 claims
- Timolol Maleate 101
Timolol Maleate
101 claims
- Dorzolamide-Timolol 95
Dorzolamide-Timolol
95 claims
- Dorzolamide Hcl 75
Dorzolamide Hcl
75 claims
- Brimonidine Tartrate 68
Brimonidine Tartrate
68 claims
- Simbrinza 46
Simbrinza
46 claims
| Drug | Claims |
|---|---|
| Latanoprost | 607 |
| Ofloxacin | 170 |
| Prednisolone Acetate | 169 |
| Timolol Maleate | 101 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 95 |
| Dorzolamide Hcl | 75 |
| Brimonidine Tartrate | 68 |
| Simbrinza Brinzolamide/Brimonidine Tart | 46 |
| Travoprost | 32 |
| Lumigan Bimatoprost | 25 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Glaucoma Specialist (Ophthalmology) Physician in CT →
All providers in Connecticut →
Compare specialties →
Glaucoma Specialist (Ophthalmology) Physician Overview
How Aron Rose, M.D. fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.
356
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider
Aron Rose, M.D.'s 1,577 claims are below the specialty average of 2,962.
Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as Rose.
Richard Boas
Wilton, CT
Dr. Gregory Gallousis
MD
Stamford, CT
Dr. Ji Liu
M.D.
New Haven, CT
Dr. Erika Wandel
MD
Waterbury, CT
Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Connecticut medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Glaucoma Specialist (Ophthalmology) Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Connecticut
Frequently Asked Questions
What is Aron Rose, M.D.'s specialty? ▼
Aron Rose, M.D. specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in Waterbury, Connecticut. Credentials: M.D..
How much does Aron Rose, M.D. prescribe under Medicare Part D? ▼
In 2023, Aron Rose, M.D. wrote 1,577 Medicare Part D claims totaling $135K in drug costs for 339 beneficiaries.
What is Aron Rose, M.D.'s Medicare quality score? ▼
Aron Rose, M.D. has a CMS MIPS Final Score of 89.4/100 (Quality: 100, Cost: 64.7). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Aron Rose, M.D. located? ▼
Aron Rose, M.D. is located at 1201 W MAIN ST, Waterbury, CT, 06708. Phone: (203) 597-9100.
What is Aron Rose, M.D.'s NPI number? ▼
Aron Rose, M.D.'s National Provider Identifier (NPI) is 1679543680, issued on 01/23/2006.
Does Aron Rose, M.D. prescribe more brand-name or generic drugs? ▼
Aron Rose, M.D.'s prescribing is 32% brand-name and 68% generic drugs by claim count, with $105K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US? ▼
There are 356 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does Aron Rose, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Aron Rose, M.D.'s most frequently prescribed drugs include Latanoprost, Ofloxacin, Prednisolone Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Aron Rose, M.D. accept Medicare? ▼
Aron Rose, M.D. appears in CMS Medicare data with 1,577 Part D claims and 339 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Aron Rose, M.D.'s credentials? ▼
Aron Rose, M.D.'s NPI is 1679543680 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.